What are the clinical signs, pathophysiology, and recommended management of an allergic reaction to a blood transfusion? | Rounds What are the clinical signs, pathophysiology, and recommended management of an allergic reaction to a blood transfusion? | Rounds
Loading...

What are the clinical signs, pathophysiology, and recommended management of an allergic reaction to a blood transfusion?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 · View editorial policy

Allergic (Hypersensitivity) Transfusion Reactions

Allergic transfusion reactions are typically type I hypersensitivity reactions to donor plasma proteins. (isbtweb.org)
Clinical manifestations range from localized urticaria/pruritus to severe anaphylaxis with airway and/or cardiovascular compromise. (isbtweb.org)

Clinical Signs and Symptoms

Mild allergic transfusion reaction

  • Localized skin rash and/or urticaria with pruritus without systemic features. (isbtweb.org)

Severe allergic transfusion reaction / anaphylaxis

  • Urticaria and other mucocutaneous findings plus systemic involvement. (isbtweb.org)
  • Respiratory findings such as throat tightness, bronchospasm, wheezing, and stridor. (isbtweb.org)
  • Cardiovascular findings such as hypotension and cardiorespiratory collapse. (isbtweb.org)
  • Angioedema, sometimes preceded by tingling around the face and lips. (isbtweb.org)

Pathophysiology

Allergic transfusion reactions are typically type I hypersensitivity reactions to donor plasma proteins. (isbtweb.org)
The implicated allergen is rarely identified. (isbtweb.org)
Severe reactions represent anaphylaxis, a life-threatening hypersensitivity reaction requiring immediate treatment. (isbtweb.org)

Immediate Assessment and Stabilization

  • Transfusion should be stopped temporarily when new symptoms/signs occur during transfusion. (b-s-h.org.uk)
  • Venous access should be maintained while assessment proceeds. (b-s-h.org.uk)
  • Vital signs should be monitored (pulse, blood pressure, temperature, respiratory rate). (b-s-h.org.uk)
  • Assess for airway, breathing, and circulation compromise because rapidly developing airway/breathing/circulation problems with skin or mucosal change suggest anaphylaxis. (b-s-h.org.uk)

Mild allergic manifestations

  • Mild allergic reactions may be managed by slowing the transfusion and giving an antihistamine. (b-s-h.org.uk)
  • For mild reactions, transfusion may be continued with direct observation in appropriate clinical settings. (b-s-h.org.uk)

Severe allergic reaction / anaphylaxis

  • Stop the transfusion and call for additional help because deterioration may occur quickly. (isbtweb.org)
  • Maintain airway and give supplemental oxygen. (isbtweb.org)
  • Administer intramuscular epinephrine (adrenaline) for anaphylaxis. (b-s-h.org.uk)
  • Bronchodilators should be used for bronchospasm. (isbtweb.org)
  • Anti-histamines and corticosteroids are probably of little use in the acute setting. (isbtweb.org)

Epinephrine (Adrenaline) Administration for Anaphylaxis

  • Intramuscular epinephrine should be given in the anterolateral thigh (middle third). (resus.org.uk)
  • Adult dose: 0.5 mg IM (500 micrograms) of 1 mg/mL (1:1000) epinephrine. (resus.org.uk)
  • Repeat IM epinephrine after 5 minutes if there is no improvement in respiratory or cardiovascular status. (resus.org.uk)

Investigation and Reporting

  • The implicated unit should be returned to the laboratory and the blood service contacted immediately for further evaluation. (b-s-h.org.uk)
  • All transfusion reactions except mild febrile and/or mild allergic reactions should be reported to appropriate haemovigilance/regulatory organizations and reviewed locally. (b-s-h.org.uk)

Prevention of Recurrence

  • In patients with recurrent allergic reactions, premedication with antihistamines prior to transfusion may be considered. (isbtweb.org)
  • For severe and/or recurrent allergic reactions with worsening symptoms, washed cellular blood products may be considered to reduce exposure to donor plasma proteins. (isbtweb.org)
  • Patients with anaphylaxis should receive future transfusions only in settings with direct observation and staff trained in managing anaphylaxis. (isbtweb.org)

Related Questions